25 studies recruiting now13 research sites across CanadaJoin the community
Home/Conditions/Parkinson’s Disease
Medical condition

Parkinson’s Disease

Plain-language information about Parkinson's disease in Canada, and what clinical research is asking about it.
Plain-language guide, not medical advice
Reading time4 min
In Canada111,000 people aged 40 and over
Studies recruitingNone right now

Parkinson’s disease is a condition in which the brain gradually loses cells that make dopamine, a chemical messenger involved in movement. Most people notice it first in how they move: a tremor, stiffness, or everything taking longer. Many also have symptoms unrelated to movement, and some of those start years earlier.

By the numbers in Canada
111,000people in Canada aged 40 and older were living with parkinsonism, including Parkinson disease, in 2022 to 2023. That is 530 out of every 100,000 people in that age group. Nearly 3 in 5 are men, almost 8 in 10 are diagnosed after 65, and on average 38 people are diagnosed every day.
Source: Public Health Agency of Canada, Canadian Chronic Disease Surveillance System, 2023
  • Parkinson Canada's January 2025 fact sheet states that more than 110,000 people are living with Parkinson's in Canada, and projects over 150,000 by 2034. It puts the share diagnosed before the age of 50 at an estimated 5 to 20%. Source: Parkinson Canada, Parkinson's fact sheet, 2025
  • The number of people in Canada living with parkinsonism rose from about 81,000 in 2012 to 2013 to about 111,000 in 2022 to 2023, while age-standardised rates stayed relatively stable. Most of the increase reflects a growing and ageing population rather than a rising individual risk. Source: Public Health Agency of Canada, 2023
  • Parkinson Canada puts the total cost of Parkinson's in Canada at 3.3 billion dollars in 2024, rising to a projected 4.4 billion by 2034. It reports that 53% of people with Parkinson's stopped working or retired early, and that care partners provide an average of 21 hours of care a week. Source: Parkinson Canada, Understanding the reality, 2024
Worldwide8.5 million people worldwide were living with Parkinson disease in 2019, and the World Health Organization says prevalence has doubled over the past 25 years. It attributes 5.8 million disability-adjusted life years and 329,000 deaths to the condition.Source: World Health Organization, 2019

What Parkinson’s disease is, and what it is not

It is not only a tremor. The World Health Organization lists slow movement, rigidity, trouble walking and imbalance alongside tremor, and Parkinson Canada adds fatigue, loss of smell, sleep disorders and changes in thinking. Some people never have a marked tremor. Parkinson Canada also notes that by the time movement symptoms appear, around half of the dopamine-producing cells have typically been lost, which is why the condition is often present before it is recognised.

It is also not the same as parkinsonism, the wider term covering Parkinson’s disease and other conditions that share its movement features, which is what Canada’s surveillance counts. Parkinson’s usually does not run in families: Parkinson Canada says the cause is unknown and about 10% of cases are thought to be familial or genetic.

Signs and symptoms

  • Slowness of movement, so tasks like dressing take longer
  • Tremor, often starting on one side and often when the limb is at rest
  • Stiffness in the limbs or trunk
  • Changes in balance and walking, including shuffling and freezing
  • A quieter voice and smaller handwriting
  • Loss of smell, disturbed sleep, fatigue, low mood or anxiety, which can start before any movement change

Which symptoms come first, and how quickly things change, differ between people.

An older adult's hands resting together on a table in soft light.
Movement symptoms are what usually lead to a diagnosis, but loss of smell, disturbed sleep and fatigue can come first. Illustrative photograph.

What raises the risk

Some things cannot be changed:

  • Getting older. Parkinson Canada calls age the primary risk factor, and almost 8 in 10 diagnoses in Canada come after 65
  • Being male. Nearly 3 in 5 people living with parkinsonism in Canada are men
  • Genetics, in about 10% of cases

Others can often be worked on, usually with support from a health care team:

  • Exposure to pesticides, industrial pollutants and other chemicals, which Parkinson Canada lists among environmental contributors. If this relates to your work, an occupational health service can review it
  • Balance and walking changes are not a cause, but they can be worked on with physiotherapy and a falls prevention plan

How Parkinson’s disease is diagnosed in Canada

No single blood test or scan confirms Parkinson’s disease. The diagnosis is clinical. A family doctor or nurse practitioner takes a history and examines you, then usually refers you to a neurologist or movement disorder specialist, who looks for the pattern of slowness, tremor, stiffness and balance change, and reviews your medicines, since some cause similar problems. Blood tests and imaging may be ordered to look for other explanations rather than to prove Parkinson’s. How you respond to medicine also informs the picture, which is why the assessment is often revisited at follow-up rather than settled in one visit.

Treatment and day-to-day management

Treatment in Canada aims at symptoms and daily function, and Parkinson Canada is clear there is no one-size-fits-all plan. A health care team may discuss:

  • Medicines that address changes in dopamine levels. The World Health Organization names levodopa combined with carbidopa as the medicine it considers most effective for symptoms and function
  • Infusion therapies, which deliver medicine continuously by pump to keep levels steadier
  • Deep brain stimulation, using implanted electrodes, usually considered several years after symptoms begin
  • Focused ultrasound, which targets a movement area of the brain without an incision, and which Parkinson Canada notes is not adjustable or reversible
  • Exercise, physiotherapy, occupational therapy, speech therapy and nutrition support
  • Counselling, peer support, and support for care partners

Which of these fits is a decision for you and your own clinician.

When to talk to a doctor

  • Call 911 for sudden weakness or numbness on one side, a drooping face, sudden trouble speaking or a sudden change in vision. These are signs of a stroke, not Parkinson’s disease, and time matters.
  • Seek urgent care after a fall with a head injury or suspected fracture, and for confusion or hallucinations coming on over hours or days, which can follow an infection or a medication change.
  • Contact your provider promptly if you are choking on food or fluids, losing weight, or if your medicines stop working the way they did.
  • Book an appointment for a new tremor, stiffness, slowness, or changes in walking, handwriting or smell. These have many causes, and assessment is how the cause gets sorted out.

Why clinical research matters for Parkinson’s disease

Parkinson’s has treatments for symptoms but nothing that stops the underlying loss of dopamine-producing cells, and Parkinson Canada’s fact sheet says plainly that there is no cure. Diagnosis is also late by nature: about half of the relevant cells have typically gone by the time movement symptoms appear, so there is no reliable way yet to identify the disease while protecting those cells might still be possible. Non-motor symptoms are common and less well treated than movement symptoms. The scale is growing: people living with parkinsonism in Canada rose from about 81,000 to about 111,000 in a decade. Research is looking at markers to identify the disease earlier, at treatments aimed at slowing it, at the movement fluctuations that develop after years of treatment, and at environmental exposures.

Studies are how those questions get answered. Taking part is voluntary, informed consent comes first, and you can stop at any time without affecting your regular care. No one can say whether a study will help you personally.

Learn more from Canadian sources

Where this information comes from (6 sources)
  1. Public Health Agency of Canada, Data blog on parkinsonism in Canada including Parkinson disease, 2023
  2. Public Health Agency of Canada, Parkinsonism and Parkinson disease, 2025
  3. Parkinson Canada, Parkinson's fact sheet, 2025
  4. Parkinson Canada, Understanding the reality, 2024
  5. Parkinson Canada, Treatments and therapies, 2026
  6. World Health Organization, Parkinson disease fact sheet, 2019

This page is written in plain language for people considering clinical research. It is general health information, not medical advice, and it does not replace a conversation with your own doctor or nurse practitioner.

Common questions

How many people in Canada have Parkinson's disease?

Canada's national surveillance system counted about 111,000 people aged 40 and older living with parkinsonism, which includes Parkinson's disease, in 2022 to 2023. That works out to 530 out of every 100,000 people in that age group. Parkinson Canada's January 2025 fact sheet gives more than 110,000 people living with Parkinson's and projects over 150,000 by 2034. The two figures count slightly different things, since parkinsonism is a wider term than Parkinson's disease, so they are not directly comparable.

Is Parkinson's disease only a movement problem?

No. Movement symptoms are what usually lead to diagnosis, but Parkinson Canada lists non-motor symptoms including fatigue, speech and writing difficulties, sleep disorders, loss of smell, depression and cognitive changes, and some of these can appear before any movement change. The World Health Organization also lists cognitive decline, mental health conditions, pain and sensory problems among the effects. Non-motor symptoms are worth raising at appointments even when they seem unrelated.

Does Parkinson's disease run in families?

Usually not. Parkinson Canada says the exact cause is unknown and that about 10% of cases are believed to be familial or genetic, with age the primary risk factor and environmental exposures such as pesticides, industrial pollutants and chemicals also contributing. Having a relative with Parkinson's does raise the question, and what it means for you is something to discuss with your own clinician.

What to do next
  1. Talk to your doctor. This guide is information, not medical advice.
  2. Check for a match. Find your study match
  3. Not ready yet? Join the community and we will write to you when something opens.
Clinical research
The JoinAStudy community
Studies for Parkinson’s Disease open regularly — join the JoinAStudy community and we'll contact you when one may fit.
Join the community →

Learn more about Parkinson’s Disease

Health blog →

Connecting Canadians with clinical research studies conducted by a network of physicians committed to advancing medicine — since 1995.

JoinAStudy.ca provides information about clinical research and does not provide medical advice, diagnosis, or treatment. Only a qualified study doctor can determine your eligibility for a study. Participation is always voluntary.

© 2026 JoinAStudy.ca · A network of Canadian physicians.|Designed by Pixelore.ca